# Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/interaction-of-the-sodium-glucose-cotransporter-sglt-2-inhibitor-canagliflozin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ryuichi Ohgaki,Ling Wei,Kazunori Yamada,Taiki Hara,Chiaki Kuriyama,Suguru Okuda,Kiichiro Ueta,Masaharu Shiotani,Shushi Nagamori,Yoshikatsu Kanai |
| Citations | 93 |
| DOI | 10.1124/jpet.116.232025 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2409050228 |
| PMID | 27189972 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Ling Wei](https://scholariq.org/researchers/ling-wei/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.